In silico Docking Approach of Coumarin Derivatives as an Aromatase Antagonist

 

Reshma Thomas, R. Hari, Josna Joy, Saranya Krishnan, Swathy A.N, Sruthy. S. Nair,

Asha Asokan Manakadan, Sathianarayanan, Saranya T.S*

Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham University, AIMS Health Sciences Campus, Ponekkara P. O., Kochi – 682041, Kerala, India

*Corresponding Author E-mail: saranyats19347@aims.amrita.edu

 

ABSTRACT:

Coumarins are pharmacologically active moiety well known for their wide variety of activities. Coumarin is the combination of benzene and pyrone ring and it belongs to benzo pyrone family. It is available from plants, microorganisms etc. Depending on various substitutions on different positions of coumarin, we get different pharmacological properties like anticancer, antioxidant, antifungal, anti-inflammatory, antiviral, anticoagulant etc.  The purpose of this study is to carry out the docking studies of coumarin derivatives containing electrophilic and nucleophilic substitutions with the anticancer target aromatase by using Arguslab version 4.0.1. Fifty four lead molecules were designed and their docking scores were compared with the standard drug Gefitinib. The validation of ligands were performed using Lipinski rule of five. It was observed that nineteen ligands showed better docking score than the standard drug Gefitinib. Phytoconstituents like Isofraxidin, Scopoletin and umbelliferone from Compositae family, which were the source of coumarin nucleus were also taken for the docking analysis. It was observed that most of the lead molecules showed higher docking score than the phytoconstituents.

 

KEYWORDS: Coumarin, Aromatase, Docking, Arguslab, Gefitinib 

 

 


INTRODUCTION:

Coumarin belongs to benzo pyron family with class name of  coumaro, the vernacular name of tonka bean (Dipeteryx odorata willd, Fabaceae) from which coumarin was isolated in 1820 [1-3]. Various coumarin derivatives are present in plant kingdom, coumarins are mostly found in essential oils found in cinnamon bark, cassia leaf, lavnder etc. They are also obtained from fruits like bilberry, cloudberry etc. Most of the coumarins are present in higher plants, and widely available from Rutaceae and umbilliferone family [4]. Some of the members of coumarins are also discovered from microorganisms, like novobiocin and coumermycin from streptomyces and aflatoxin  from Aspergillus species.

 

Coumarins can be synthesized in lab by various chemical reactions and depending upon different  substitutions on coumarin it will produce derivatives with different biological activities like antimicrobial, antioxidant, anticoagulant, antiviral, anti-inflammatory, anticancer etc[5-13]. Aromatase is an enzyme belonging to cytochrome p450 family. It has been observed that the main cause of breast cancer is increase in the level of estrogen. Researches in this field denotes that, coumarin have inhibitory activity on aromatase, which is a key enzyme in the biosynthesis of estrogen from androgen[14]. Therefore, the objective of the study was to develop coumarin derivatives and to check their potency and toxicity against the known cancer targets.

 

Fig 1: Chemical structure of coumarin nucleus

MATERIALS AND METHODS:

Fifty four lead molecules were designed by using chemsketch by giving substitutions on  3rd, 4th, 5th, 6th, 7th and 8th positions of coumarin nucleus as shown in fig:1. In this study gefitinib was selected as the reference drug, which is an anticancer drug [15].

 

 

Docking study:

Molecular docking:

Docking is a method, which predicts the preferred orientation of one molecule to a second when bound to each other to form a stable complex. Here the docking was performed using the software Argus lab 4.0.1. All the water molecules in the protein were removed and docked with designed ligands to check the affinity expressed in terms of the docking score. Then the ligand score was compared with the score of reference drug to determine the efficiency of the designed lead molecules.


 

 

RESULTS AND DISCUSSION:

Table 1. Analysis of Lipinski Rule of Five for novel proposed analogues of coumarin

Sl. No

Name of the compound

Molecular weight

No. of Hba

No. of Hbd

C log p

No of Rot. b

No. of violations

1

3- Bromo Coumarin

225.041

2

0

2.751

0

0

2

4- Bromo Coumain

225.041

2

0

2.751

0

0

3

5-Bromo Coumarin

225.041

2

0

2.775

0

0

4

6-Bromo Coumarin

225.041

2

0

2.799

0

0

5

7-Bromo Coumarin

225.041

2

0

2.799

0

0

6

8-Bromo Coumarin

225.041

2

0

2.775

0

0

7

3-Chloro Coumarin

180.59

2

0

2.62

0

0

8

4- Chloro Coumarin

180.59

2

0

2.62

0

0

9

5-Chloro Coumarin

180.59

2

0

2.64

0

0

10

6-Chloro Coumarin

180.59

2

0

2.668

0

0

11

7-Chloro Coumarin

180.59

2

0

2.668

0

0

12

8-Chloro Coumarin

180.59

2

0

2.64

0

0

13

3- Fluoro Coumarin

164.135

2

0

1.133

0

0

14

4- Fluoro Coumarin

164.135

2

0

2.105

0

0

15

5- Fluoro Coumarin

164.135

2

0

2.129

0

0

16

6- Fluoro Coumarin

164.135

2

0

1.181

0

0

17

7- Fluoro Coumarin

164.135

2

0

2.153

0

0

18

8- Fluoro Coumarin

164.135

2

0

2.129

0

0

19

3- Iodo Coumarin

272.041

2

0

3.025

0

0

20

4-Iodo Coumarin

272.041

2

0

3.025

0

0

21

5-Iodo Coumarin

272.041

2

0

3.049

0

0

22

6-Iodo Coumarin

272.04

2

0

3.073

0

0

23

7-Iodo Coumarin

272.04

2

0

3.073

0

0

24

8-Iodo Coumarin

272.041

2

0

3.049

0

0

25

3-Hydroxy Coumarin

162.14

3

1

1.723

0

0

26

4- Hydroxy Coumarin

162.14

3

1

1.723

0

0

27

5 -Hydroxy Coumarin

162.14

3

1

1.747

0

0

28

6 -Hydroxy Coumarin

162.14

3

1

1.511

0

0

29

7-Hydroxy Coumarin

162.14

3

1

1.511

0

0

30

8-Hydroxy Coumarin

162.14

2

0

1.511

0

0

31

3-MethoxyCoumarin

176.171

3

0

1.998

0

0

32

4-Methoxy Coumarin

176.171

3

0

1.998

0

0

33

5-Methoxy Coumarin

176.171

3

0

2.022

0

0

34

6-Methoxy Coumarin

176.171

3

0

2.046

0

0

35

7-Methoxy Coumarin

176.171

3

0

2.046

0

0

36

8-MethoxyCoumarin

176.171

3

0

2.022

0

0

37

3- Ethoxy Coumarin

190.18

3

0

2.374

0

0

38

4-Ethoxy Coumarin

190.18

3

0

2.374

0

0

39

5-Ethoxy Coumarin

190.18

3

0

2.398

0

0

40

6-Ethoxy Coumarin

190.18

3

0

2.422

0

0

41

7-Ethoxy Coumarin

190.18

3

0

2.422

0

0

42

8-Ethoxy Coumarin

190.18

3

0

2.422

0

0

43

3- Nitro Coumarin

191.14

5

0

1.901

0

0

44

4 -Nitro Coumarin

191.14

5

0

1.901

0

0

45

5- Nitro Coumarin

191.14

5

0

1.901

0

0

46

6 -Nitro Coumarin

191.14

5

0

1.901

0

0

47

7 -Nitro Coumarin

191.14

5

0

1.901

0

0

48

8 -Nitro Coumarin

191.14

5

0

1.901

0

0

49

2oxo-2H-chromene-3-carbaldehyde

174.155

3

0

1.732

0

0

50

2oxo-2H-chromene-4-carbaldehyde

174.155

3

0

1.732

0

0

51

2oxo-2H-chromene-5-carbaldehyde

174.155

3

0

1.732

0

0

52

2oxo-2H-chromene-6-carbaldehyde

174.155

3

0

1.732

0

0

53

2oxo-2H-chromene-7-carbaldehyde

174.155

3

0

1.732

0

0

54

2oxo-2H-chromene-8-carbaldehyde

174.155

3

0

1.732

0

0

 

Phytoconstituents

 

 

 

 

 

 

1

Isofraxidin      

222.2

5

1

1.54

2

0

2

Scopoletin  

192.17

4

1

1.33

1

0

3

Umbilliserone 

176.17

3

1

1.89

0

0

 


Selection of target:

The target selected was the aromatase inhibitor having PDB id 3S7S as the target [16].

 

Preparation of ligands:

The ligands were designed and their smiles notations were obtained from ChemSketch, which is a chemically intelligent drawing, interface freeware developed by Advanced Chemistry Department. The designed ligands were saved in PDB format, which is acceptable to all docking software.

 

 

 

Validation of ligands

The molecular properties based on Lipinski rule of five and the drug ADME were checked using the software Molinspiration, the results are compiled in the Table 1 and 2.

 

The results of the validation of ligands shows that the values of all fifty four compounds and three phytoconstituents based on molecular weight is less than 500 Daltons, number of hydrogen bond donors and hydrogen bond acceptors are below 5 and 10, partition coefficient lies within the limits of 5. The results shows that there is no violation of Lipinski rule of five.


 

Bioactivity study:

Table 2. Bioactivity results of proposed analogues of coumarin

Sl no

Name of compound

GPCR ligand

Ion channel modulator

Kinase inhibitor

Nuclear receptor ligand

Protease inhibitor

Enzyme inhibitor

1

3-Bromo Coumarin

-1.37

-0.83

-1.29

-1.21

-1.35

-0.58

2

4-Bromo Coumain

-1.29

-0.93

-1.19

-1.10

-1.36

-0.54

3

5-Bromo Coumarin

-1.34

-0.97

-1.29

-1.35

-1.44

-0.57

4

6-Bromo Coumarin

-1.63

-1.52

-1.46

-1.54

-1.55

-0.66

5

7-Bromo Coumarin

-1.63

-0.91

-1.61

-1.63

-1.68

-1.69

6

8-Bromo Coumarin

-1.49

-1.03

-1.59

-1.42

-1.43

-0.53

7

3-Chloro Coumarin

-1.45

-1

-1.48

-1.27

-1.33

-1.58

8

4-Chloro Coumarin

-1.29

-1.65

-1.26

-1.08

-1.31

-1.55

9

5-Chloro Coumarin

-1.30

--0.67

-1.36

-1.29

-1.36

-0.57

10

6-Chloro Coumarin

-1.27

-0.75

-1.40

-1.26

-1.32

-1.53

11

7-Chloro Coumarin

-1.24

-0.65

--1.53

-1.21

-1.35

-0.53

12

8-Chloro Coumarin

-1.45

-1

-1.48

-1.27

-1.33

-.0.52

13

3- Fluoro Coumarin

-1.13

-0.71

-1.32

-1.23

-1.37

-0.60

14

4- Fluoro Coumarin

-1.13

-0.69

-1.06

-0.92

-1.22

-0.46

15

5- Fluoro Coumarin

-1.13

-0.71

-1.14

--1.12

-1.29

-0.40

16

6- Fluoro Coumarin

-1.20

-0.75

-1.30

-1.15

-1.33

-0.47

17

7- Fluoro Coumarin

-1.09

-0.65

-1.25

-1.26

-1.27

-0.46

18

8- Fluoro Coumarin

-1.29

-0.67

-1.30

-1.01

-1.33

-0.42

19

 3-Iodo Coumarin

-1.24

-0.60

-1.17

-0.96-1.

-1.27

-0.53

20

4-Iodo Coumarin

-1.16

-0.67

-1.07

-0.99

-1.23

-0.57

21

5-Iodo Coumarin

-1.26

-0.70

-1.04

-1.19

-1.29

-0.60

22

6-Iodo Coumarin

-1.31

-0.69

-1.26

-1.19

--1.44

-0.59

23

7-Iodo Coumarin

-1.31

-0.69

-1.26

-1.19

-1.44

-0.59

24

8-Iodo Coumarin

-1.24

-0.71

-1.32

-0.23

-1.37

-0.60

25

3-Hydroxy Coumarin

-1.11

-0.59

-1.13

-0.78

-1.14

-0.23

26

4-Hydroxy Coumarin

-1.29

-0.49

-1.51

-1.02

-1.08

-0.27

27

5-Hydroxy Coumarin

-1.21

-0.59

-1.32

-1.12

-1.17

-0.28

28

6-Hydroxy Coumarin

-1.15

-0.64

-1.22

-0.69

-1.26

-0.23

29

7-Hydroxy Coumarin

-1.22

-0.72

-1.30

-0.92

-1.30

-0.35

30

8-Hydroxy Coumarin

-1.02

-0.64

-1.30

-1.11

-1.12

-0.24

31

3-MethoxyCoumarin

-1.08

-0.67-

-1.05

-0.86

-1.12

-0.31

32

4-Methoxy Coumarin

-1.22

-0.58

-1.24

-1.12

-1.08

-0.41

33

5-Methoxy Coumarin

-1.15

-0.67

-1.25

-1.21

-1.16

-0.42

34

6-Methoxy Coumarin

-1.15

-0.67

-1.25

-1.21

-1.16

-1.42

35

7-Methoxy coumarin

-1.19

-0.51

-1.27

-1.19

-1.26

-0.48

36

8-MethoxyCoumarin

-1.19

-0.91

-1.27

-1.19

-1.28

-0.48

37

3- EthoxyCoumarin

-1.14

-0.53

-1.18

-0.93

-0.99

-0.39

38

4-EthoxyCoumarin

-1.09

-0.70

-1.15

-0.85

-1.14

-0.42

39

5-EthoxyCoumarin

-1.15

-0.77

-1.22

-0.67

-1.18

-0.45

40

6-EthoxyCoumarin

-1.09

-0.70

-1.15

-0.85

-1.14

-0.42

41

7-EthoxyCoumarin

-1.15

-0.77

-1.22

-0.67

-1.18

-0.65

42

8-EthoxyCoumarin

-1.11

-0.84

-1.21

-0.99

-1.17

-0.46

43

3-Nitro Coumarin

-1.07

-0.67

-1.21

-0.99

-1.20

-0.47

44

4-Nitro Coumarin

-1.15

-0.64

-0.94

-0.93

-1.42

-1.40

45

5-Nitro Coumarin

-1.22

-0.58

-1.12

-1.03

-1.38

-0.48

46

6-Nitro Coumarin

-1.21

-0.63

-1.24

-1.08

-1.22

-0.46

47

7-Nitro Coumarin

-1.29

-0.66

-1.37

-1.10

-1.28

-0.54

48

8-Nitro Coumarin

-1.06

-0.65

-0.96

-1.15

-1.13

-0.36

49

2oxo-2H-chromene-3-carbaldehyde

-1.19

-0.84

-1.24

-0.76

-1.19

-0.42

50

2oxo-2H-chromene-4-carbaldehyde

-1.36

-0.94

-1.15

-0.66

-1.46

-0.48

51

2oxo-2H-chromene-5-carbaldehyde

-1.21

-0.84

-1.12

-0.82

-1.40

-0.46

52

2oxo-2H-chromene-6-carbaldehyde

-1.26

-0.78

-1.29

-0.94

-1.40

-0.461

53

2oxo-2H-chromene-7-carbaldehyde

-1.29

-0.71

-1.35

-1.01

-1.44

-0.50

54

1

2

3

2oxo-2H-chromene-8-carbaldehyde

Phytoconstituents

Isofraxidin Scopoletin

Umbilliserone

-1.21

-0.88

-1.00

-1.31

-0.87

-0.34

-0.65

-1.10

-1.25

-0.76

-0.95

-1.18

-1.01

-0.76

-0.81

-0.62

-1.45

-0.94

-1.16

-139

-0.51

-0.06

-0.24

-0.40

 


Docking Analysis:

The docking scores were obtained for the designed coumarin derivatives against aromatase receptor and the scores are as given in Table .3

 

Table 3. Docking scores for 54 novel proposed analogues of coumarin by using Arguslab 4.0.1

Sl

No:

Substitution

Docking Score

(kcal/mol)

1

3-Bromo Coumarin

-9.7

2

4- Bromo Coumain

-9.7

3

5-Bromo Coumarin

-9.6

4

6-Bromo Coumarin

-9.6

5

7-Bromo Coumarin

-9.2

6

8-Bromo Coumarin

-9.5

7

3-Chloro Coumarin

-9.4

8

4-Chloro Coumarin

-8.9

9

5-Chloro Coumarin

-9.7

10

6-Chloro Coumarin

-9.3

11

7-Chloro Coumarin

-9.2

12

8-Chloro Coumarin

-9.4

13

3-  Fluoro Coumarin

-9

14

4-Fluoro Coumarin

-8.4

15

5- Fluoro Coumarin

-8.9

16

6- Fluoro Coumarin

-8.6

17

7- Fluoro Coumarin

-8.8

18

8- Fluoro Coumarin

-8.9

19

3-Iodo Coumarin

-9.8

20

4-Iodo Coumarin

-9.4

21

5-Iodo Coumarin

-9.5

22

6-Iodo Coumarin

-9.6

23

7-Iodo Coumarin

-9.1

24

8-Iodo Coumarin

-9.1

25

3-Hydroxy Coumarin

-8.6

26

4-Hydroxy Coumarin

-8.3

27

5-Hydroxy Coumarin

-8.2

28

6-Hydroxy Coumarin

-8

29

7-Hydroxy Coumarin

-7.8

30

8-Hydroxy Coumarin

-8.2

31

3-Methoxy Coumarin

-8

32

4-Methoxy Coumarin

-8.29

33

5-Methoxy Coumarin

-8.34

34

6-Methoxy Coumarin

-7.4

35

7-Methoxy Coumarin

-7.8

36

8-Methoxy Coumarin

-8.2

37

3- Ethoxy Coumarin

-9.1

38

4-Ethoxy Coumarin

-8.2

39

5-Ethoxy Coumarin

-8.1

40

6-Ethoxy Coumarin

-8.3

41

7-Ethoxy  Coumarin

-8.2

42

8-Ethoxy Coumarin

-8.1

43

3- Nitro Coumarin

-8.7

44

4- Nitro Coumarin

-8.4

45

5- Nitro Coumarin

-7.93

46

6- Nitro Coumarin

-7.94

47

7- Nitro Coumarin

-8.32

48

8- Nitro Coumarin

-8.64

49

2oxo-2H-chromene-3-carbaldehyde

-8.40

50

2oxo-2H-chromene-4-carbaldehyde

-8.25

51

2oxo-2H-chromene-5-carbaldehyde

-8.69

52

2oxo-2H-chromene-6-carbaldehyde

-8.07

53

2oxo-2H-chromene-7-carbaldehyde

-8.27

54

2oxo-2H-chromene-8-carbaldehyde

-8.51

55

Gefitinib(standard drug)

-8.9

 

The docking scores were obtained for the phytoconstituents having coumarin nucleus against aromatase receptor and the scores are as given in      Table. 4

 

 

Table. 4 Docking scores of phytoconstituents having coumarin nucleus using argus lab 4.0.1

Sl. No

Phytoconstituent

Docking Score(Kcal/mol)

1

 Isofraxidin 

-6.8

2

Scopoletin

-7.16

3

Umbillierone

-8.4

 

 

It was observed that among bromine substituted coumarins, 3-bromo coumarin and 4-bromo coumarin showed best docking score (Fig. 2 and 3)

 

 Fig. 2-bromo coumarin                           

 Fig. 3 bromo coumarin

 

Among the chlorine-substituted coumarin 5-chloro coumarin shows best docking score (fig.4)

 

Fig.4-chloro coumarin

 

Among the fluorine substituted coumarin 3- Fluoro coumarin showed best docking score (fig.5)

 

 

Fig.5- Fluoro coumarin

 

Among the iodine substituted coumarin 3-iodo coumarin showed best docking score (fig.6)

 

 

Fig.6- iodo coumarin

 

Among the hydroxyl substituted coumarin 3-hydroxy coumarin showed best docking score (fig.7)

 

 

Fig.7-hydroxy coumarin

 

Among  the methoxy substituted coumarin 5-methoxy coumarin showed best docking score (fig.8)

 

 

Fig.8-methoxy coumarin

 

Among  the ethoxy substituted coumarin 3-ethoxy coumarin showed best docking score (fig.9)

 

 

Fig.9-ethoxy coumarin

 

Among the nitro substituted coumarin 3-nitro coumarin showed best docking score (fig.10)

 

 Fig.10   3-nitro coumarin

 

Among the aldehyde substituted coumarin 2 oxo 2H –chromene- 5 carbaldehyde showed best docking score (fig.11)

 

Fig.11 2oxo-2H-chromene-5 carbaldehyde

 

Among the fifty four compounds nineteen designed analogues of coumarin shows good docking score compared to the reference drug Gefitinib, which is a drug used in the treatment of breast cancer. Among 19 derivatives  3-iodo coumarin showed best docking score than the reference drug gefitinib.

 

CONCLUSION:

The docking studies conducted in coumarin for its anti cancer properties was successful and from that we came to a conclusion that coumarin derivatives with iodine substitution at the third position of the heterocyclic ring showed good docking score compared to the standard drug gefitinib and  three phytoconstituent having coumarin pharmacophore. From the present study we could also finalise that the substitutions at the third position of coumarin ring with several electron withdrawing groups such as bromo, fluoro, and nitro and electron releasing group such as hydroxyl substitution demonstrate best affinity with the aromatase receptors. The phytoconstituents of coumarin shows less docking score as compared with these ligands.

 

ACKNOWLEDGEMENTS:

We are thankful to Department of Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, for providing necessary facilities for the study.

REFERENCES:

1.     P.K Jain, Himanshu Joshi. Coumarin: chemical and pharmacological profile. Journal Of Applied Pharmaceutical Science  2012; 2 supp 6: 236-240

2.     Aoife Lacy and Richard O’Kennedy. Studies on Coumarins and Coumarin - Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer. Current Pharmaceutical Design 2004; 10: 3797-3811.

3.     F. Borges1, F. Roleira, N. Milhazes and L. Santana and E. Uriarte. Simple Coumarins and Analogues in Medicinal Chemistry: Occurrence, Synthesis and Biological Activity. Current Medicinal Chemistry 2005; 12: 887-916

4.     S. Mirunalini, M. Krishnaveri: Coumarin: A  Plant Derived Polyphenol  With Wide Biomedical Applications. International Journal of Pharma Tech Research, 2011; 3 supp 3 :1693-1696

5.     R.M Patel, R.N Sharma and N.J Patel. In-vitro Cytotoxic Screening of 4 Methyl-2h-chromen-2-one derivatives against  Hep 2 cell line. Asian Journal of Biochemical and Pharmaceutical Research2011; 1 suppl 2:2231-2560

6.     K.N. Venugopala, V. Rashmi, and B. Odhav. Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity. BioMed Research International, 2013;

7.     Adriana Basile, Sergio Sorbo , Vivienne Spadaro , Maurizio Bruno, Antonella Maggio, Nicoletta Faraone and Sergio Rosselli. Antimicrobial and Antioxidant Activities of Coumarins from the Roots of Ferulago campestris (Apiaceae). Molecules 2009; 14: 939-952

8.     Bhatnagar A., Sharma P. K., Kumar N, Dudhe R. A review on “Recent advances in Coumarin derivatives with their multidisciplinary actions”. Scholars Research Library,2010; 2 suppl 4:297-306

9.     Batra Nikhil, Batra Shikha, Pareek Anil, Nagori Badri Prakash. Diverse Pharmacological Activities of 3-Substituted coumarins. International Research Journal of Pharmacy 2012.; 3 suppl 7:2230 -8437

10.  Mohd. Mudassir Husain, Rajeev. Vibrational Spectra and Electronic Structural Studies of Some Coumarins. Internatioal Journal of Research in Engineering and Sciences, 2013;1 supp 3: 2320-9364

11.  Rajesh. N. Gacche and Sharad. G. Jadhav. Anti oxidant Activities And Cytotoxicity of selected coumarin derivatives : preliminary Results of a Structural -Activity  Relationship  Study using  computational Journal. Journal of Experimental And Clinical Medicine 2012; 3 suppl 4:165-169 

12.  Deepthy Chandran, Leena. K. Pappachen, Manju Prathap, Jinsha.G. Insilico Drug Design And Molecular  Docking Studies  Of  Some Novel Benzothiazole Derivatives  As Anti-Cancer  And  Anti-inflammatory agents. International Journal Of Pharmacy And Pharmaceutical Sciences 2014;6 suppl 2:203-208.

13.  Sadia rahman, Muhammad Ikkram, Robert J Baker, Muhammad  Z ubair, Effat Azad, Soyoung Min, Kashif Riyas, K.H Mok, Saeed-ur Rahman. Synthesis, characterization, in –vitro  Anti- microbial and U2OS tumoricidal activities of different coumarin derivatives. Chemistry Central Journal, 2013;7:68

14.  Koneni V. Sashidhara, Srinivasa Rao Avula, Komal Sharma, Gopala Reddy Palnati and Surendar Reddy Bathula. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent. European Journal Of  Medicinal Chemistry,201; 60:120-127

15.  Qiong Gao, Neill Patani, Anita K. Dunbier, Zara Ghazoui , Marketa Zvelebil, Lesley-Ann Martin.  Effect of Aromatase Inhibition on Functional Gene Modules in Estrogen Receptor–Positive Breast Cancer and Their Relationship with Antiproliferative Response. Clinical Cancer Research, 201;20 suppl 2:2484-2494.

16.  Shahnawaz Ahmad, Amit Chattree , Sikander Dar. In Silico, Study of Flavonoids and their potential application as Anti-Cancer Agents. International Journal of Science and Research, 2012; 11 Suppl 3:586-589.

 

 

 

 

 

Received on 24.10.2015             Modified on 04.11.2015

Accepted on 21.11.2015           © RJPT All right reserved

Research J. Pharm. and Tech. 8(12): Dec., 2015; Page 1673-1678

DOI: 10.5958/0974-360X.2015.00302.9